Sironi G, Montagna E, Greto L, Leonardi A, Testa R
Pharmaceutical R&D Division, Recordati S.p.A., Milan, Italy.
Arzneimittelforschung. 1996 Mar;46(3):256-61.
In this study, the haemodynamic effects of lercanidipine (CAS 132866-11-6, Rec 15/2375) in anaesthetized open-chest dogs were investigated in comparison with nitrendipine. Intravenously administered lercanidipine induced a dose-related, long-lasting reduction in systemic and coronary vascular resistances, with concomitant decrease in arterial blood pressure and increase in coronary blood flow. The hypotensive ED25 was 6.1 micrograms/kg and 4.2 micrograms/kg (decrease of mean blood pressure and of total peripheral resistances, respectively) and the ED50 on coronary vasodilation, 4.8 micrograms/kg 7.8 micrograms/kg (increase of coronary blood flow and decrease in coronary vascular resistances, respectively). The time-course of the haemodynamic effects was investigated after administration of 5 micrograms/kg. A slow onset of haemodynamic vasodilation and long-lasting activity were observed, since peak effects on mean blood pressure and coronary blood flow occurred at 20 and 30 min after the administration, respectively, and the effects on systemic and coronary resistances were still significant at 30 and 150 min after administration, respectively. A reflex, non-dose-dependent increase in heart rate was observed after the administration of 10 and 30 micrograms/kg, which was absent with the 5 micrograms/kg dose. As far as cardiac contractility was concerned, the contractile index dP/dtmax and dP/dt/P were analyzed. In the dose-response study, dP/dtmax was practically not affected. In the time-course study, dP/dtmax was not modified after administration of 5 micrograms/kg, and dP/dt/P showed a slight but long-lasting increase. Haemodynamic investigation confirmed in vivo the high vascular selectivity of lercanidipine and a lack of sympathetic reflex activation at vasodilating doses.
在本研究中,与尼群地平相比,研究了乐卡地平(CAS 132866-11-6,Rec 15/2375)对麻醉开胸犬的血流动力学影响。静脉注射乐卡地平可引起剂量相关的、持久的全身和冠状动脉血管阻力降低,同时动脉血压下降,冠状动脉血流量增加。降压ED25分别为6.1微克/千克和4.2微克/千克(平均血压和总外周阻力降低),冠状动脉血管舒张的ED50分别为4.8微克/千克和7.8微克/千克(冠状动脉血流量增加和冠状动脉血管阻力降低)。在给予5微克/千克后研究了血流动力学效应的时程。观察到血流动力学血管舒张起效缓慢且作用持久,因为平均血压和冠状动脉血流量的峰值效应分别在给药后20分钟和30分钟出现,对全身和冠状动脉阻力的影响在给药后30分钟和150分钟仍显著。在给予10微克/千克和30微克/千克后观察到反射性、非剂量依赖性心率增加,而给予5微克/千克剂量时未出现。就心脏收缩性而言,分析了收缩指数dP/dtmax和dP/dt/P。在剂量反应研究中,dP/dtmax实际上未受影响。在时程研究中,给予5微克/千克后dP/dtmax未改变,dP/dt/P显示轻微但持久的增加。血流动力学研究在体内证实了乐卡地平的高血管选择性以及在血管舒张剂量下缺乏交感反射激活。